We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
262 hedge funds and large institutions have $3.56B invested in Acadia Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 80 increasing their positions, 84 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
105% more call options, than puts
Call options by funds: $35.6M | Put options by funds: $17.3M
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
81% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 26
7% more funds holding
Funds holding: 246 → 262 (+16)
4% more capital invested
Capital invested by funds: $3.44B → $3.56B (+$120M)
0.95% less ownership
Funds ownership: 92.19% → 91.24% (-0.95%)
5% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 84
Holders
262
Holders Change
+16
Holders Change %
+6.5%
% of All Funds
4.13%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
47
Increased
80
Reduced
84
Closed
26
Calls
$35.6M
Puts
$17.3M
Net Calls
+$18.3M
Net Calls Change
-$52.8M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$109M |
| 2 |
PA
Perceptive Advisors
New York
|
-$31.4M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$24.7M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$20.7M |
| 5 |
N
Natixis
Paris,
France
|
-$13.5M |
